Markowitz SD - Search Results

1

E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma.

Lynch HT, Grady W, Lynch JF, Tsuchiya KD, Wiesner G, Markowitz SD. Lynch HT, et al. Among authors: markowitz sd. Cancer Genet Cytogenet. 2000 Oct 1;122(1):1-6. doi: 10.1016/s0165-4608(00)00273-9. Cancer Genet Cytogenet. 2000. PMID: 11104024

2

hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds.

Liu B, Parsons RE, Hamilton SR, Petersen GM, Lynch HT, Watson P, Markowitz S, Willson JK, Green J, de la Chapelle A, et al. Liu B, et al. Cancer Res. 1994 Sep 1;54(17):4590-4. Cancer Res. 1994. PMID: 8062247

3

What's new with RII?

Grady W, Rajput A, Myeroff L, Markowitz S. Grady W, et al. Gastroenterology. 1997 Jan;112(1):297-302. doi: 10.1016/s0016-5085(97)70249-x. Gastroenterology. 1997. PMID: 8978374 No abstract available.

4

Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas.

Grady WM, Rajput A, Myeroff L, Liu DF, Kwon K, Willis J, Markowitz S. Grady WM, et al. Cancer Res. 1998 Jul 15;58(14):3101-4. Cancer Res. 1998. PMID: 9679977

5

Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK, Markowitz S. Grady WM, et al. Cancer Res. 1999 Jan 15;59(2):320-4. Cancer Res. 1999. PMID: 9927040

6

E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.

Guilford PJ, Hopkins JB, Grady WM, Markowitz SD, Willis J, Lynch H, Rajput A, Wiesner GL, Lindor NM, Burgart LJ, Toro TT, Lee D, Limacher JM, Shaw DW, Findlay MP, Reeve AE. Guilford PJ, et al. Among authors: markowitz sd. Hum Mutat. 1999;14(3):249-55. doi: 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9. Hum Mutat. 1999. PMID: 10477433

7

Conversion of diploidy to haploidy.

Yan H, Papadopoulos N, Marra G, Perrera C, Jiricny J, Boland CR, Lynch HT, Chadwick RB, de la Chapelle A, Berg K, Eshleman JR, Yuan W, Markowitz S, Laken SJ, Lengauer C, Kinzler KW, Vogelstein B. Yan H, et al. Nature. 2000 Feb 17;403(6771):723-4. doi: 10.1038/35001659. Nature. 2000. PMID: 10693791 No abstract available.

8

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.

Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S. Grady WM, et al. Nat Genet. 2000 Sep;26(1):16-7. doi: 10.1038/79120. Nat Genet. 2000. PMID: 10973239

9

Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer.

Grady WM, Rajput A, Lutterbaugh JD, Markowitz SD. Grady WM, et al. Among authors: markowitz sd. Cancer Res. 2001 Feb 1;61(3):900-2. Cancer Res. 2001. PMID: 11221878

10

Testing for colon neoplasia susceptibility variants at the human COX2 locus.

Wiesner GL, Platzer P, Buxbaum S, Lewis S, MacMillen M, Olechnowicz J, Willis J, Chakravarti A, Elston RC, Markowitz SD. Wiesner GL, et al. Among authors: markowitz sd. J Natl Cancer Inst. 2001 Apr 18;93(8):635-9. doi: 10.1093/jnci/93.8.635. J Natl Cancer Inst. 2001. PMID: 11309440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

268 results

Search Page